Benign Prostatic Hyperplasia Devices Market Size, Share | 2028
[Research Report] The benign prostatic hyperplasic devices market is expected to grow from US$ 2,078.78 million in 2021 to US$ 3,467.31 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2022 to 2028.
Benign prostatic hyperplasia (BPH) is a prostate enlargement caused by excessive cell growth in the prostate. BPH is a benign (non-cancerous) prostate condition. Non-cancerous conditions are not usually fatal and do not spread (metastasize) to other body parts. BPH doesn't raise the risk of prostate cancer; unless it manifests symptoms, BPH isn't considered a health issue. Almost all men will have some prostate growth by the age of 70. Getting older, having more belly fat (also known as abdominal obesity), and not getting enough exercise to raise the risk of developing BPH.
The benign prostatic hyperplasic devices market is segmented into product, procedure type, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. This report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends, market dynamics, and the competitive analysis of the globally leading market players.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Benign Prostatic Hyperplasic Devices Market: Strategic Insights
Market Size Value in US$ 2,078.78 Million in 2021 Market Size Value by US$ 3,467.31 million by 2028 Growth rate CAGR of 7.6% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Benign Prostatic Hyperplasic Devices Market: Strategic Insights
| Market Size Value in | US$ 2,078.78 Million in 2021 |
| Market Size Value by | US$ 3,467.31 million by 2028 |
| Growth rate | CAGR of 7.6% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Increase in prevalence of benign prostatic hyperplasia along with growing risk factors, and a rise in investments, funds, and grants for research in BPH treatment to drive benign prostatic hyperplasic devices market.
Increase in prevalence of benign prostatic hyperplasia along with growing risk factors, and a rise in investments, funds, and grants for research in BPH treatment to drive benign prostatic hyperplasic devices market.
According to the National Center for Biotechnology Information (NCBI), BPH is one of the most common disorders in older men and the leading cause of lower urinary tract symptoms (LUTS). After the age of 40, the prevalence of BPH rises, reaching a peak of 60% by the age of 90. According to autopsy studies, the histological prevalence of BPH is 8%, 50%, and 80% in the fourth, sixth, and ninth decades of a man's life, respectively. Old age has also been shown to be a risk factor for the onset and progression of clinical BPH in observational studies conducted in Europe, the US, and Asia. According to statistics from the Krimpen and Baltimore Longitudinal Study of Aging, the prostate grows at a rate of 2.0% to 2.5% per year in older men. Continued prostate enlargement is a risk factor for developing LUTS, and larger prostates are associated with a benign prostatic enlargement (BPE), which triggers the risk of developing clinical BPH and urine incontinence.
According to NCBI data, increased adiposity is found to have a positive correlation with prostate volume. In numerous study groups, body weight, body mass index (BMI), and waist circumference have been seen to have a positive correlation with prostate volume. Additionally, epidemiological data shows obesity may raise the necessity of BPH surgery and initiating BPH treatment.
According to the American Journal of Men's Health (AJMH), in 2019, globally, there were 11.26 million new cases and 1.86 million Years Lived with Disability (YLD) due to BPH in 2019. The incidence of BPH increased by 105.7%, and YLD increased by 110.6% worldwide during 1990–2019. The absolute incidence and YLD numbers increased considerably worldwide during this period, primarily due to population increase and aging. As per the estimates by UROLOGY FOUNDATION, in the UK, the prevalence of BPH rises from 50% among men aged 50–60 to 90% among men aged 80 and above. Some men develop sudden acute retention, i.e., the inability to pass urine. The treatment option for BPH includes surgeries such as transurethral resection of the prostate (TURP), open prostatectomy, and minimally invasive treatments such as transurethral needle ablation (TUNA). In minimally invasive treatments such as radiofrequency ablation, laser therapy, and implants, benign prostatic hyperplasic devices are used. Thus, the increase in the prevalence of benign prostatic hyperplasia and increasing risk factors are bolstering the demand for benign prostatic hyperplasic devices.
Product Insights
Based on the product, the benign prostatic hyperplasic devices market is segmented into resectoscopes, radiofrequency ablation devices, urology lasers, prostatic stents, and implants. The resectoscopes segment is likely to hold the largest market share in 2022. However, the urology lasers segment is anticipated to register the highest CAGR during the forecast period due to the high demand by physicians and the rising initiatives of market players in the launch and product expansion.
Procedure Type Insights
Based on procedure type, the benign prostatic hyperplasic devices market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others. In 2022, the transurethral resection of the prostate segment is likely to hold the market's largest share. Furthermore, the same segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to its visual, hands-on access to the prostate, ability to immediate removal of excess tissue, the ability of transurethral resection of the prostate (TURP) to combine with other procedures.
End User Insights
Based on end user, the benign prostatic hyperplasic devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment is likely to hold the largest share of the market. Moreover, the clinics segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to an increase in the number of clinics at a lower cost for treatment, easy accessibility, and flexibility with the short waiting time.
Organic developments such as product launches and approvals are highly adopted strategies by the global benign prostatic hyperplasic devices market players. A few of the recent key market developments are listed below:
- In April 2022, Teleflex Incorporated launched the UroLift System in Japan for treating BPH or enlarged prostate. The system was made available for purchase immediately after the launch.
- In April 2020, Olympus announced the approval of iTind, its nonsurgical medical device, for the minimally invasive surgery of BPH. This is a temporarily urethral opening device that has been given a De Novo classification by the FDA and is a Class II medical device.
Benign Prostatic Hyperplasic Devices Market - Segmentation
The global benign prostatic hyperplasic devices market is segmented into product, procedure type, end user, and geography. Based on product, the market is segmented into resectoscopes, radiofrequency ablation devices, urology lasers, prostatic stents, and implants. Based on the procedure type, the market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others. Based on end user, the market is differentiated into hospitals, clinics, ambulatory surgical centers, and others. By geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.
Benign Prostatic Hyperplasia Devices Market Report Scope
Benign Prostatic Hyperplasic Devices Market - Company Profiles
- KARL STORZ SE & Co. KG
- Richard Wolf GmbH
- Olympus Corporation
- Urologix, LLC.
- Boston Scientific Corporation
- Butterfly
- TELEFLEX Incorporated
- OmniGuide Holdings, Inc.
- Convergent Laser Technologies
- ProArc
- Olympus Corporation
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Procedure Type, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Benign prostatic hyperplasia (BPH) is a prostate enlargement caused by excessive cell growth in the prostate. BPH is a benign (non-cancerous) prostate condition. Non-cancerous conditions are not usually fatal and do not spread (metastasize) to other body parts. BPH doesn't raise the risk of prostate cancer; unless it manifests symptoms, BPH isn't considered a health issue. Almost all men will have some prostate growth by the age of 70. Getting older, having more belly fat (also known as abdominal obesity), and not getting enough exercise to raise the risk of developing BPH.
The factors that are driving and restraining factors that will affect the benign prostatic hyperplasic devices market in the coming years. Factors such as the rise in the prevalence of benign prostatic hyperplasia amongst men, along with increasing risk factors and rise in investments, funds, and grants for research in BPH treatment. However, less awareness about prostate health among men will hamper the market growth.
The global benign prostatic hyperplasic devices market based on product is resectoscopes, radiofrequency ablation devices, urology laser, prostatic stents, and implants. The resectoscopes segment is likely to hold the largest share of the market in 2022. However, the urology lasers segment is anticipated to register the highest CAGR of 8.4% in the market during the forecast period.
The benign prostatic hyperplasic devices market majorly consists of the players such as KARL STORZ SE & Co. KG; Richard Wolf GmbH; Olympus Corporation; Urologix, LLC.; Boston Scientific Corporation; Butterfly; TELEFLEX Incorporated; OmniGuide Holdings, Inc.; Convergent Laser Technologies; ProArc; and Olympus Corporation.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Benign Prostatic Hyperplasic Devices Market – By Product
1.3.2 Global Benign Prostatic Hyperplasic Devices Market – By Procedure Type
1.3.3 Global Benign Prostatic Hyperplasic Devices Market – By End User
1.3.4 Global Benign Prostatic Hyperplasic Devices Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Benign Prostatic Hyperplasic Devices Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Benign Prostatic Hyperplasic Devices Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Benign Prostatic Hyperplasia along with Growing Risk Factors
5.1.2 Rise in Investments, Funds, and Grants for Research in BPH Treatment
5.2 Market Restraints
5.2.1 Low Awareness of Prostate Health Among Men
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Product Approvals and Launches
5.5 Impact Analysis
6. Benign Prostatic Hyperplasic Devices Market – Global Analysis
6.1 Global Benign Prostatic Hyperplasic Devices Market Revenue Forecast and Analysis
6.2 Global Benign Prostatic Hyperplasic Devices Market, By Geography - Forecast and Analysis
6.3 Global Benign Prostatic Hyperplasic Devices Market – Market Potential Analysis, By Region
6.4 Company Analysis
6.4.1 Market Positioning of Key Players
6.4.2 Comparative Company Analysis
6.5 Growth Strategy Analysis
6.6 Performance of Key Players
6.6.1 Olympus Corporation
6.6.2 Butterfly Medical
7. Global Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028 – by Product
7.1 Benign Prostatic Hyperplasic Devices Market Revenue Share, by Product (2022 and 2028)
7.2 Resectoscopes
7.2.1 Overview
7.2.2 Resectoscopes: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.3 Urology Lasers
7.3.1 Overview
7.3.2 Urology Lasers: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Radiofrequency Ablation Devices
7.4.1 Overview
7.4.2 Radiofrequency Ablation Devices: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Prostatic Stents
7.5.1 Overview
7.5.2 Prostatic Stents: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Implants
7.6.1 Overview
7.6.2 Implants: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Benign Prostatic Hyperplasic Devices Market Analysis and Forecast to 2028 - by Procedure Type
8.1 Benign Prostatic Hyperplasic Devices Market Revenue Share, by Procedure Type (2022 and 2028)
8.2 Transurethral Microwave Therapy
8.2.1 Overview
8.2.2 Transurethral Microwave Therapy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Transurethral Resection of the Prostate
8.3.1 Overview
8.3.2 Transurethral Resection of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Transurethral Needle Ablation of the Prostate
8.4.1 Overview
8.4.2 Transurethral Needle Ablation of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Laser Surgery
8.5.1 Overview
8.5.2 Laser Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.6 UroLift Surgery
8.6.1 Overview
8.6.2 UroLift Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
9. Global Benign Prostatic Hyperplasic Devices Market Analysis and Forecast to 2028 – by End User
9.1 Overview
9.2 Benign Prostatic Hyperplasic Devices Market Revenue Share, by End User (2022 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 – Geographical Analysis
10.1 North America: Benign Prostatic Hyperplasic Devices Market
10.1.1 Overview
10.1.2 North America: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Benign Prostatic Hyperplasic Devices Market, by Product, 2019–2028 (US$ Million)
10.1.4 North America: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019–2028 (US$ Million)
10.1.5 North America: Benign Prostatic Hyperplasic Devices Market, by End User, 2019–2028 (US$ Million)
10.1.6 North America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
10.1.6.1 US: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Benign Prostatic Hyperplasic Devices Market, by Product, 2019–2028 (US$ Million)
10.1.6.1.4 US: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019–2028 (US$ Million)
10.1.6.1.5 US: Benign Prostatic Hyperplasic Devices Market, by End User, 2019–2028 (US$ Million)
10.1.6.2 Canada: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Benign Prostatic Hyperplasic Devices Market, by Product, 2019–2028 (US$ Million)
10.1.6.2.4 Canada: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019–2028 (US$ Million)
10.1.6.2.5 Canada: Benign Prostatic Hyperplasic Devices Market, by End User, 2019–2028 (US$ Million)
10.1.6.3 Mexico: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Benign Prostatic Hyperplasic Devices Market, by Product, 2019–2028 (US$ Million)
10.1.6.3.4 Mexico: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019–2028 (US$ Million)
10.1.6.3.5 Mexico: Benign Prostatic Hyperplasic Devices Market, by End User, 2019–2028 (US$ Million)
10.2 Europe: Benign Prostatic Hyperplasic Devices Market
10.2.1 Overview
10.2.2 Europe: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.2.4 Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
10.2.5 Europe: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6 Europe: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
10.2.6.1 UK: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 UK: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 UK: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.4 UK: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.5 UK: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2 Germany: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 Germany: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 Germany: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.4 Germany: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.5 Germany: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3 France: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 France: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 France: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.4 France: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.5 France: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4 Italy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.4 Italy: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.5 Italy: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5 Spain: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.4 Spain: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.5 Spain: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6 Rest of Europe: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.5 Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028
10.3.1 Overview
10.3.2 Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.4 Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.5 Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6 Asia Pacific: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
10.3.6.1 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.6.1.4 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.6.1.5 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.2 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.6.2.4 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.6.2.5 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.3 India Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.6.3.4 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.6.3.5 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.4 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.6.4.4 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.6.4.5 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.5 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.6.5.4 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.6.5.5 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.6 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.4 Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028
10.4.1 Overview
10.4.2 Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.4.5 Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By End User (US$ Million)
10.4.6 Middle East & Africa: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
10.4.6.1 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.4.6.1.4 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.4.6.1.5 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By End User (US$ Million)
10.4.6.2 South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 South Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.4.6.2.4 South Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.4.6.2.5 South Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.4.6.3 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.4.6.3.4 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.4.6.3.5 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By End User (US$ Million)
10.4.6.4 Rest of Middle East and Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East and Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.4.6.4.5 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast To 2028, By End User (US$ Million)
10.5 South And Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028
10.5.1 Overview
10.5.2 South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.5.3 South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.5.4 South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.5.5 South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.5.6 South and Central America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
10.5.6.1 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.5.6.1.4 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.5.6.1.5 Brazil: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2 Argentina Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Argentina Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.5.6.2.4 Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.5.6.2.5 Argentina: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3 Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market– Revenue and Forecast to 2028 (USD Mn)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market– Revenue and Forecast to 2028 (USD Mn)
10.5.6.3.3 Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.5.6.3.4 Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.5.6.3.5 Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Benign Prostatic Hyperplasic Devices Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Benign Prostatic Hyperplasic Devices Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Benign Prostatic Hyperplasia Devices Market
12.3 Inorganic Growth Strategies
12.4 Organic Growth Strategies
13. Company Profiles
13.1 KARL STORZ SE & Co. KG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Richard Wolf GmbH
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Olympus Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Urologix, LLC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Boston Scientific Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Butterfly
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Teleflex Incorporated
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 OmniGuide Holdings, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Convergent Laser Technologies
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ProArc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms for Benign Prostatic Hyperplasia Devices Market
LIST OF TABLES
Table 1. North America Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 2. North America Benign Prostatic Hyperplasic Devices Market, by Procedure Type– Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 5. US Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Europe: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 17. UK: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. UK: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. Germany: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 20. Germany: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
Table 21. Germany: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22. France: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 23. France: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. France: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million).
Table 35. Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 36. Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 37. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 38. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 39. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 40. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 41. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 42. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 43. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 44. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 45. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 46. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 47. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 48. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 49. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 50. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 51. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 52. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 53. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 54. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 55. Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 56. Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 57. Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 58. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 59. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 60. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 61. South Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 62. South Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 63. South Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 64. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 65. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 66. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 67. Rest of Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 68. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 69. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 70. South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 71. South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 72. South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 73. Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 74. Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 75. Brazil: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 76. Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 77. Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 78. Argentina: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
Table 80. Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
Table 81. Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 82. Recent Inorganic Growth Strategies in the Benign Prostatic Hyperplasia Devices Market
Table 83. Recent Organic Growth Strategies in the Benign Prostatic Hyperplasia Devices Market
Table 84. Glossary of Terms
LIST OF FIGURES
Figure 1. Benign Prostatic Hyperplasic Devices Market Segmentation
Figure 2. Benign Prostatic Hyperplasic Devices Market, By Region
Figure 3. Global Benign Prostatic Hyperplasic Devices Market Overview
Figure 4. Resectoscopes Segment Held Largest Share of Product Segment in Benign Prostatic Hyperplasic Devices Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Benign Prostatic Hyperplasic Devices Market, by Geography (US$ Million)
Figure 7. Global Benign Prostatic Hyperplasic Devices Market- Leading Country Markets (US$ Million)
Figure 8. Global Benign Prostatic Hyperplasic Devices Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Global Benign Prostatic Hyperplasic Devices Market – Revenue Forecast and Analysis – 2020-2028
Figure 16. Global Benign Prostatic Hyperplasic Devices Market – By Geography Forecast and Analysis – 2022- 2028
Figure 17. Global Benign Prostatic Hyperplasic Devices Market – Market Potential Analysis, By Region
Figure 18. Market Positioning of Key Players In Global Benign Prostatic Hyperplasic Devices Market
Figure 19. Global Benign Prostatic Hyperplasic Devices Market – Comparative Company Analysis
Figure 20. Global Benign Prostatic Hyperplasic Devices Market – Growth Strategy Analysis
Figure 21. Benign Prostatic Hyperplasic Devices Market Revenue Share, by Product (2022 and 2028)
Figure 22. Resectoscopes: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Urology Lasers: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Radiofrequency Ablation Devices: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Prostatic Stents: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Implants: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Benign Prostatic Hyperplasic Devices Market Revenue Share, by Procedure Type (2022 and 2028)
Figure 28. Transurethral Microwave Therapy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Transurethral Resection of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Transurethral Needle Ablation of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Laser Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. UroLift Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Others: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Benign Prostatic Hyperplasic Devices Market Revenue Share, by End User (2022 and 2028)
Figure 35. Hospitals Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. Clinics Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. Ambulatory Surgical Centers Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. North America: Benign Prostatic Hyperplasic Devices Market, by Key Country – Revenue (2022) (US$ Million)
Figure 40. North America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 41. North America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
Figure 42. US: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Canada: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Mexico: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Europe: Benign Prostatic Hyperplasic Devices Market, by Key Country – Revenue (2022) (US$ Million)
Figure 46. Europe: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 47. Europe: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
Figure 48. UK: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Germany: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. France: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Italy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Spain: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Rest of Europe: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Asia Pacific Benign Prostatic Hyperplasic Devices Market Overview, by Country (2021)
Figure 55. Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 56. Asia Pacific: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
Figure 57. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 58. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 59. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 60. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 61. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 62. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 64. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 65. Middle East & Africa: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
Figure 66. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 67. South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 68. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 69. Rest of Middle East and Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 70. South and Central America Benign Prostatic Hyperplasic Devices Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 71. South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 72. South and Central America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
Figure 73. Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 74. Argentina Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 75. Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market– Revenue and Forecast to 2028 (USD Mn)
Figure 76. Impact of COVID-19 Pandemic in North American Country Markets
Figure 77. Impact of COVID-19 Pandemic in European Country Markets
Figure 78. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 79. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 80. Impact Of COVID-19 Pandemic in South and Central America Country Markets
The List of Companies - Benign Prostatic Hyperplasic Devices Market
- KARL STORZ SE & Co. KG
- Richard Wolf GmbH
- Olympus Corporation
- Urologix, LLC.
- Boston Scientific Corporation
- Butterfly
- TELEFLEX Incorporated
- OmniGuide Holdings, Inc.
- Convergent Laser Technologies
- ProArc
- Olympus Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For